DNA content analysis in thyroid neoplasms: Diagnostic and prognostic interest;Étude du contenu en ADN nucléaire dans les nodules thyroïdiens: Intérêt diagnostique et pronostique

Annales d'Endocrinologie

Volumn 66, Issue 4, 2005, Pages 333-339

  Missaoui, N ^a   Hmissa, S ^a   Mokni, M ^a   Trabelsi, A ^a   Trimech, M ^a   Lagueb, I ^a   Yacoubi, Mt ^a   Sriha, B ^a   Korbi, S ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Diagnosis; Ploidy; Prognosis; Thyroid; Tumors

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CELL CYCLE S PHASE; DIAGNOSTIC TEST; DNA CONTENT; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM LYMPH NODE; PLOIDY; PROGNOSIS; THYROID CELL; THYROID NODULE; THYROID TUMOR; TISSUE FIXATION; CELL DIVISION; CELL NUCLEUS; CHEMISTRY; GENETICS; MIDDLE AGED; PATHOLOGY;

DNA;

ANEUPLOIDY; CELL DIVISION; CELL NUCLEUS; DNA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; S PHASE; THYROID NEOPLASMS;

EID: 25844505726     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4266(05)81790-1     Document Type: Article

References (29)

1. Bengtsson A, Malmaeus J, Grimelius L, et al. Measurement of nuclear DNA content in thyroid diagnosis. World J Surg 1984; 8: 481-486.
2. Brocheriou C. Carcinome anaplasique de la thyroïde. Arch Anat Cytol Path 1998; 46: 87-93.
3. Cary FA. Measurement of nuclear DNA content in histological and cytological specimens: principles and applications. J Pathol 1994; 172: 307-312.
4. Castro P, Sansonetty F, Soares P, Dias A, Sorbinho-Simoes M. Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern. Virchows Arch 2001; 438: 336-342.
5. Cotran RS, Kumar V, Collins T. La glande thyroïde. Le système endocrinien. In: Robbins Anatomie Pathologique, Bases morphologiques et physiologiques des maladies, Padoue, 2000, pp: 1367-75.
6. Cerutti JM, Delcelo R, Amadei MJ, et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 2004; 113: 1234-1242.
7. Chieco P, Derenzini M. The Feulgen reaction 75 years on. Histochem Cell Biol 1999; 111: 345-358.
8. Christov K. Flow Cytometric DNA measurements in human thyroid tumors. Virchows Arch B Cell Pathol Incl Mol Pathol 1986; 51: 255-263.
9. Delgado R, Mikuz G, Hofstadter F. DNA-Feulgen-cytophotometric analysis of single cells isolated from paraffin embedded tissue. Path Res Pract 1984; 179: 92-94.
10. Fonseca E, Sobrinho-Simoes M. Diagnostic Problems in differentiated carcinomas of the thyroid. Path Res Pract 1995; 191: 318-331
11. Fossa SD, Thorud E, Vaage S, Shoa MC. DNA cytometry of primary breast ancer: comparison of microspectrophotometry and flow cytometry. Acta Pathol Microbiol Immunol Scand [A] 1983; 91: 235-243.
12. Grant CS, Hay ID, Ryan JJ, Bergstralh EJ, Rainwter LM, Goelliner JR. Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg 1990; 14: 283-290.
13. Greenebaum E, Koss LG, Elequin F, Silver CE. The diagnostic value of flow cytometric DNA measurements in follicular tumors of the thyroid gland. Cancer 1985; 56: 2011-2018.
14. Hedinger CR, William ED, Sobin LH. Histological typing of thyroid tumours in international classification of tumours. World health organization ed. Springer-Verlag, Berlin, 1988, pp.5-14.
15. Kiss R, Salmon I, Camby I, Gas S, Pasteels JL. Characterisation of factors in routine laboratory protocols that significantly influence the Feulgen reaction. J Histochem Cytochem 1993; 41: 935-945.
16. Lang W, Georgii A, Stauch G, Kienzle E. The differentiation of atypical adenomas and follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histopathol 1980; 385: 125-141.
17. Livolsi VA. Papillary neoplasms of the thyroid: Pathology and prognostic features. Am J Clin Pathol 1992; 97: 426-434.
18. Lyon HO, Schulte EK, Prento P, Barer MR, Bene MC. Standardized staining methods: Feulgen-Rossenbeck reaction for deoxyribonucleic acid and periodic acid-schiff (PAS) procedure. Biotech Histochem 2002; 77: 121-125.
19. Mackenzie EJ, Mortimer RH. Thyroid nodules and thyroid cancer. Med J Aust 2004; 180: 242-7.
20. Mcleod MK. The measurement of DNA content and ploidy analysis in thyroid neoplasms. Otolaryngol Clin North Am 1990; 23: 271-290.
21. Nadjari B, Motherby H, Pooschke T, et al. DNA aneuploidy as a specific marker of neoplastic cell in FNAB of the thyroid. Anal Quant Cytol Histol 1999; 21: 481-488.
22. Quirke P, Dyson JE. Flow cytometry: Methodology and applications in pathology. J Pathol 1986; 149: 79-87.
23. Ross JS. DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. Oncology (Huntingt) 1996; 10: 867-890.
24. Salmon I, Gasperin P, Pasteels JL, et al. Ploidy level and proliferative activity measurements in as series of 407 thyroid tumors or other pathologic conditions. Hum Pathol 1993; 24: 912-920.
25. Salmon I, Kiss R. Relationship between proliferative activity and Ploidy level in a series of 530 human brains tumors, including astrocytomas, meningiomas, schwannomas and metastases. Hum Pathol 1993; 24: 329-335.
26. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med 1998; 338: 297-306.
27. Sheppard MC, Franklyn JA. Management of the single thyroid nodule. Clin Endocrinol 1992; 37: 398-401.
28. Sturgis CD, Caraway NP, Johnston DA, Sherman SI, Kidd L, Katz RL. Image analysis of papillary thyroid carcinoma fine needle aspirates, significant association between aneuploidy and death from disease. Cancer 1999; 87: 155-160.
29. Suissa J, Hoang C, Soubrane C, et al. Cytométrie en flux des tumeurs de la thyroïde, Etude sur tissu frais chez 50 malades. Presse Med 1994; 23: 159-163.